GlassScriptPhysician profile
Nathan D Fairbourn
NPI 1952967291
$4,278.69
in general payments reported to CMS, 2019-2025
16 companies · $498 in 2025
The $498 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,816 · 2024: $1,966 · 2025: $498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,481 · Food and Beverage: $1,775 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,481.01 |
| Food and Beverage | $1,774.84 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,183.56 | 2023-2024 | Da Vinci Sp, Da Vinci Surgical System |
| Astellas Pharma US INC | $288.31 | 2023-2025 | Veozah |
| Davol INC. | $191.25 | 2023-2025 | Arista Ah Flexitip, Arista |
| Organon LLC | $109.76 | 2023-2025 | Nexplanon, Jada System |
| Sage Therapeutics, LLC | $91.81 | 2024-2025 | Zurzuvae |
| Exact Sciences Corporation | $79.71 | 2024-2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $74.68 | 2024-2025 | Myfembree |
| Evofem Biosciences, INC. | $50.19 | 2023-2024 | Phexxi |
| Hologic Sales and Service, LLC | $45.15 | 2024 | Aptima, Acessa Provu System |
| Mayne Pharma Commercial LLC | $37.36 | 2025 | |
| Exeltis, USA INC. | $31.52 | 2025 | Slynd |
| Organogenesis INC. | $26.83 | 2025 | Cygnus Dual |
| Bayer Healthcare Pharmaceuticals INC. | $21.87 | 2024 | |
| Supernus Pharmaceuticals, INC. | $15.66 | 2025 | Qelbree |
| Abbvie INC. | $15.61 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.42 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Fairbourn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.